Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World test gauges pain relief Devices' safety

NCT ID NCT06809283

Knowledge-focused Sponsor: DJO UK Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This study follows 144 adults with muscle or bone problems who are already scheduled to receive treatment with Chattanooga Intelect devices (like TENS or ultrasound). Researchers will measure pain, muscle strength, and movement range to confirm the devices are safe and work as expected in everyday medical practice. It is an observational study, meaning no new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chattanooga Intelect devices (TENS, ultrasound, electrotherapy, NMES)
What this could lead to
If successful, this study will confirm that these devices are safe and work well for everyday muscle and bone pain treatment.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only tracks routine use, not new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

144 people

The number who actually took part.

Started

Mar 2025

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with musculoskeletal and skeletal muscle deficit disorders planned to be treated with any of the Intelect® devices who spontaneously went to any of the selected sites for receiving a treatment. For the purpose of determining the type of performance data to be collected, patients will be assigned to two groups: TENS/US group or NMES group based on the treatment they receive during their first session.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients with musculoskeletal and skeletal muscle deficit disorders assigned to be treated with any of the Intelect® devices according to the current clinical practice at the selected sites and based on the opinion of the Investigator. 2. Patient male or female with age ≥18 years old. 3. Patient able to provide written informed consent. For France only: To be affiliated to the social security system or to be beneficiary of such system Exclusion Criteria: 1. Patients participating in another clinical study or who have completed a clinical study less than 30 days prior to enrollment. 2. Patients who for any reason e.g. significant co-morbidities or other reasons, are considered by the Investigator unsuitable for study participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Muscle disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

muscle tissue disorder musculoskeletal system disorder Pain skeletal muscle disorder skeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Muscle disorder Musculoskeletal disorders Skeletal disorder

Contacts and locations

Locations

  • Attal Cabinet

    Serris, France

  • Casertafisio

    Caserta, 81100, Italy

  • Dr Chad Woods Physiotherapy

    Peebles, EH45, United Kingdom

  • Rachis Center

    Roma, 00199, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.